Expansion push: South Korean postbiotic supplier seeks overseas entry after domestic boom

By Tingmin Koe

- Last updated on GMT

TERA Biotics 1 is a consumer product containing posbiotics by Bereum.
TERA Biotics 1 is a consumer product containing posbiotics by Bereum.

Related tags Bereum postbiotics

South Korea-based postbiotic ingredient and finished product firm Bereum is now pursuing growth in overseas markets following steep growth in the domestic market in the past two years.

Bereum is behind the postbiotic ingredient EF-2001 isolated from the gut of a healthy infant as well as other postbiotics, namely L. plantarum, L. casei, ​and L. acidophilus​ isolated from kimchi and grape wine.

It also develops its own finished products, including powder sachet TERA Biotics 1, omega-3 postbiotics that is sold online, microbiome mask sheet, and pet supplement powder sachet Pet-I 3000, in addition to providing OEM services.

Speaking to NutraIngredients-Asia ​at Vitafoods Asia, Robin Jeong, manager of sales, said that the company would be expanding its overseas business. 

“We have been supplying our postbiotic ingredients to food and beverage and pharmaceutical companies in South Korea and decided to expand to the overseas markets last year,” ​Jeong said, adding that there were more than 200 brands using its postbiotics.  

Some of the consumer brands that they have worked with are from the food and beverage, as well as pharmaceutical industries, including Maeil, Pulmuone, and Dongwon.

One of its latest endeavours is to register its postbiotic product as a health supplement in Kuwait, while Asia and America would be the company's key target markets, Jeong said.

At the moment, the firm is running three clinical trials in India to find out the effects of postbiotics on gut health, immunity, and fat reduction.

Currently, the firm owns a factory in the Gangwon province where it could manufacture postbiotics into the form of softgel, powder, beverage, and film.

Saturated probiotics market drives diversification

Postbiotic or parabiotic related health claims are not yet allowed in South Korea.

However, many companies are using the word ‘postbiotic’ in their brand name, trade name, or product name as they sought new growth opportunities in an increasingly saturated probiotics market, according to a regulatory expert.

Internationally, postbiotics has been defined as​ ‘a preparation of inanimate microorganisms and/or their components that confers a health benefit on the host.’

“Postbiotic is not a big market in South Korea so far, but a couple of companies, including Korean and some European companies are starting the promotion of postbiotics.

“The market is now growing and we expect it to grow further, because the classical probiotic market is already saturated.

“Many companies are trying to find a new source, a new expression, and a new ingredient which is the spin-off from probiotics, and that would be the postbiotics or parabiotics,” ​said regulatory expert Dr. Sun-Ho Frank Kim, founder of Seah Bio Solutions.   

An example of a probiotic brand that has expanded into the postbiotic space is South Korean brand Esther, he said. 

Aside from health supplements, postbiotics has also found its way into skincare products.

“Postbiotics is still a very new concept to consumers, they do not know what it is. But the important thing is everyone knows what probiotics are, so based on consumers’ awareness of probiotics, companies are promoting postbiotics as a new concept of probiotics.

“For example, they have been promoting very aggressively on TV shopping and SNS the word ‘postbiotics’, which is why consumers’ awareness is growing,” ​Dr. Kim said.

Related news

Show more

Related products

show more

Whitepaper: Discover a new era in postbiotics

Whitepaper: Discover a new era in postbiotics

Content provided by DSM Nutritional Products | 28-Nov-2023 | White Paper

Postbiotic ingredients are set to open up a world of opportunities across the human health and nutrition industry, fueled by developing science demonstrating...

Taking Immune Support to a New Level

Taking Immune Support to a New Level

Content provided by AB Biotek Human Nutrition & Health | 30-Oct-2023 | White Paper

Patent-pending ABB C1® redefines immune support by addressing innate, acquired, and Trained Immunity. In 'ABB C1®: Training Now for Future Immune...

Related suppliers

Follow us

Products

View more

Webinars

Nutra Champions Podcast

Nutra Champions Podcast